UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 85 filers reported holding UTAH MED PRODS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,478 | +10.1% | 546 | +17.2% | 0.00% | – |
| Q1 2024 | $33,137 | -45.0% | 466 | -34.8% | 0.00% | – |
| Q4 2023 | $60,216 | -2.1% | 715 | -0.1% | 0.00% | – |
| Q3 2023 | $61,534 | +2.3% | 716 | +10.8% | 0.00% | – |
| Q2 2023 | $60,161 | +20.3% | 646 | +22.3% | 0.00% | – |
| Q1 2023 | $49,991 | +163.1% | 528 | +182.4% | 0.00% | – |
| Q4 2022 | $19,000 | +18.8% | 187 | 0.0% | 0.00% | – |
| Q3 2022 | $16,000 | -11.1% | 187 | -7.4% | 0.00% | – |
| Q2 2022 | $18,000 | 0.0% | 202 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | -18.2% | 202 | -4.7% | 0.00% | – |
| Q4 2021 | $22,000 | +4.8% | 212 | -4.9% | 0.00% | – |
| Q3 2021 | $21,000 | +10.5% | 223 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | 0.0% | 223 | +0.5% | 0.00% | – |
| Q1 2021 | $19,000 | +137.5% | 222 | +128.9% | 0.00% | – |
| Q4 2020 | $8,000 | -68.0% | 97 | -67.6% | 0.00% | – |
| Q3 2020 | $25,000 | -7.4% | 299 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | -18.2% | 299 | -16.7% | 0.00% | – |
| Q1 2020 | $33,000 | – | 359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Partners LP | 271,139 | $16,282,000 | 5.30% |
| MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 188,732 | $11,333,000 | 2.93% |
| Opus Capital Group, LLC | 36,877 | $2,214,000 | 0.32% |
| Clean Yield Group | 8,581 | $515,000 | 0.23% |
| Ativo Capital Management LLC | 7,372 | $443,000 | 0.18% |
| Ancora Advisors LLC | 22,009 | $1,322,000 | 0.16% |
| Penobscot Investment Management Company, Inc. | 6,000 | $360,000 | 0.11% |
| Wallace Capital Management Inc. | 9,010 | $541,000 | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,300 | $2,180,000 | 0.05% |
| CONNORS INVESTOR SERVICES INC | 3,591 | $216,000 | 0.05% |